Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Dr Lisa Holland

Dr Lisa Holland

Contact information


lisa.holland@ndph.ox.ac.uk

Lisa Holland

PhD

Research Facilitator

Lisa is Research Facilitator for the Mexico City Prospective Study – a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.

She joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2006 as a member of the Vascular Overviews Group. Lisa worked on the meta-analyses of clinical trials of statins (Cholesterol Treatment Trialists Collaboration), of non-steroidal anti-inflammatory drugs (Coxib and NSAID Trialists Collaboration), and of angiotension receptor blockers for the treatment of Marfan Syndrom.

Lisa Holland completed an undergraduate degree in Biochemistry with Microbiology at Lancaster University and a PhD in Molecular Microbiology at the University of Nottingham.

Recent publications

More publications